Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leveraging preclinical models of metastatic breast cancer

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2024)10.1016/j.bbcan.2024.189163Source: DataRank Database

Leveraging preclinical models of metastatic breast cancer is a research paper published in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 1.56)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Yang Gao ORCID,Xiang H.-F. Zhang ORCID,Jeffrey M. Rosen ORCID,Diego A. Pedroza ORCID

Live enrichment

PubMed:39084494 PMC:PMC11390310 OpenAlex:https://openalex.org/W4401075773

American Cancer Society

Grant: K99CA27989

American Cancer Society

Grant: R01CA016303-46

American Cancer Society

Grant: PF-22-163-01-MM

American Cancer Society

Grant: R01CA148761-13

American Cancer Society

Grant: SAC232150

National Institutes of Health

Grant: T32CA203690

U.S. Department of Defense

Grant: R01CA227904

U.S. Department of Defense

Grant: R01CA221946

U.S. Department of Defense

Grant: DAMD W81XWH-20-1-0375

U.S. Department of Defense

Grant: R01CA183878

U.S. Department of Defense

Grant: R01CA251950

U.S. Department of Defense

Grant: DAMD W81XWH-16-1-0073

NCI NIH HHS

Grant: K99 CA279899

NCI NIH HHS

Grant: R01 CA016303

NCI NIH HHS

Grant: R01 CA148761

NCI NIH HHS

Grant: P50 CA186784

NCI NIH HHS

Grant: T32 CA070091

Breast Cancer Research Foundation

Susan G. Komen

Robert and Janice McNair Foundation

FWCI

1.56

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11390310/pdf/nihms-2019445.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0304419X24000945?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304419X24000945?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11390310

Fields of Study

Cancer Immunotherapy and BiomarkersCancer Cells and MetastasisImmunotherapy and Immune ResponsesBreast NeoplasmsHumansFemaleAnimalsTumor MicroenvironmentNeoplasm MetastasisDisease Models, AnimalXenograft Model Antitumor Assays

MeSH Terms

AnimalsBreast NeoplasmsDisease Models, AnimalFemaleHumansNeoplasm MetastasisXenograft Model Antitumor AssaysTumor Microenvironment

Keywords

MedicineMetastatic breast cancerBreast cancerBlockadeCancerTumor microenvironmentOncologyMetastasisDiseasePrimary tumorImmune checkpointImmune systemCancer researchInternal medicineImmunotherapyImmunologyReceptorChemotherapyTumor Immune MicroenvironmentPreclinical Mouse Models

Sustainable Development Goals

SDG 0: Good health and well-being

Leveraging preclinical models of metastatic breast cancer

FAIR Checklist

Authors (4)

Funding (20 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)